Tranexamic Acid Use in Elective Cesarean Section for Women With Placenta Previa
NCT ID: NCT03060889
Last Updated: 2017-02-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
86 participants
INTERVENTIONAL
2016-02-29
2016-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy of Tranexamic Acid In Reducing Blood Loss During Cesarean Section Because Of Placenta Previa
NCT02688127
Effectiveness of Intravenous Tranexamic Acid in Reducing Blood Loss During and After Cesarean Section
NCT02279186
Efficacy of Topical Tranexamic Acid in Reducing Blood Loss During CS in Patients With Placenta Previa
NCT06515535
Reducing Blood Loss During Cesarean Section by Topical Versus IV Tranexamic Acid
NCT03706339
Antenatal Tranexamic Acid in Women With Symptomatic Placenta Previa
NCT04055194
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cases
Tranexamic acid 10 mg/ kg body weight will be given by intravenous infusion with induction of anesthesia in elective cesarean section for non complicated cases of placenta previa
Tranexamic acid
10 mg/kg body weight will be given with induction of anesthesia by intravenous infusion
Controls
Control group will not receive Tranexamic acid
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Tranexamic acid
10 mg/kg body weight will be given with induction of anesthesia by intravenous infusion
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosis of placenta previa was confirmed by ultrasound
* The patient hemoglobin percentage is more than 10 mg/dl
Exclusion Criteria
* Emergency lower segment cesarean section
* Associated medical comorbidities
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ain Shams University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ahmed Elsayed Hassan Elbohoty
Principal Investigator
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AAbdelaziz
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.